Document LpgwQ54M94ZnwE9ELj84dyaJd

t Vinyl Chloride Panel Health Committee Phase 10 Financial Statement August, 1993 through September, 1996 REVENUE: Company Commitments ENSR Interest Total $1,655,424 14,000 40.383 $1,709,807 EXPENSES/COMMITMENTS Activity Budgeted Epidemiology Study Update Applied Epidemiology, Inc. ENSR Dow Consulting Brain Cancer Case-Control Study University of Louisville Protocol Peer Reviewer Consultants Reproductive, Developmental and Mechanistic Research Studies Huntingdon Laboratories University of North Carolina 13C2 Vinyl Chloride Synthesis Dow Consulting GEON Shipment of Vinyl Chloride Contingency Risk Assessment Reitz Reitz Swenberg ILSI Outside Counsel Administration Contingency Including Earned Interest 450,000 10,000 40,000 120,000 6,900 600,000 50,000 11,200 25,000 10,000 63,800 598 4,498 548 10,000 40,000 190,000 To Date 77,263 Total 1,787,070 (P) Proposed Expenses or Commitment 437,395 9,261 40,000 120,000 3,038 600,000 50,000 11,200 25,000 10,000 598 4,498 548 10,000 34,895 138,180 SL 110106